Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs PDS Biotechnology Corporation (PDSB)

Compass Therapeutics, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Compass Therapeutics, Inc. and PDS Biotechnology Corporation are of similar size ($136.7M and $129.2M). Across the 8 metrics below, PDS Biotechnology Corporation leads on 5 and Compass Therapeutics, Inc. on 3.

Valuation

Metric CMPX PDSB Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.86 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (52.63%) (52.03%) (32.88%)
Free cash flow yield (39.71%) (24.15%) (23.13%)

Profitability

Metric CMPX PDSB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) (543.97%) (51.96%)
Return on assets (47.87%) (136.65%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX PDSB Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (16.67%) 28.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 11.22 0.57 4.97
Net debt to EBITDA 2.86 0.50 1.01

Dividend

Metric CMPX PDSB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMPX PDSB Biotechnology median
Market cap 136.65m 129.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack